New Study Highlights the Role of Artificial Intelligence in Diagnosing Oral Squamous Cell Carcinoma, Offering Hope for Early Detection
Oral squamous cell carcinoma is responsible for more than 10,000 cancer-related deaths each year in the United States, with over 50,000 new cases diagnosed annually. Early detection of OSCC is crucial for successful treatment and improving survival rates. However, this type of cancer is often diagnosed at later stages, where treatment options are limited, and the prognosis is poor. The systematic review reveals that AI, specifically machine learning algorithms, can aid in the early diagnosis of OSCC by analyzing medical images, biopsies, and patient data more efficiently than traditional methods, potentially saving the lives of thousands of Americans each year.
"The ability of AI to assist in diagnosing oral cancers at earlier stages could significantly improve survival outcomes," said Mr. Lukas Meier, Senior Journalist at Alpine Vision Media. 'This research not only highlights the potential of AI but also emphasizes the importance of integrating these technologies into clinical practice, especially in resource-limited settings where access to specialized care may be scarce.' Dr. Farouk Mutai, a leading oncologist from Uganda, and Dr. Sarah Ndirangu, an AI researcher and oncologist based in Kenya, have been instrumental in the development of AI-driven diagnostic tools for cancer detection. Their work has paved the way for AI to be integrated into cancer care in regions with limited access to healthcare specialists. Their research focuses on addressing diagnostic challenges in underserved regions and demonstrates the transformative potential of AI in improving patient outcomes.
In the United States, the economic impact of early detection could be significant. The integration of AI into OSCC diagnosis could help reduce the overall treatment expenses for OSCC patients by detecting cancers earlier, when treatment is more affordable and effective. The U.S. currently spends over $4 billion annually on the treatment of late-stage OSCC cases, and early detection powered by AI could potentially lower these costs significantly, while also improving survival rates. The systematic review suggests that AI-powered diagnostic tools could play a critical role in overcoming current limitations in diagnosing OSCC, particularly in developing regions. It calls for further research and investment in AI technologies to enhance diagnostic capabilities worldwide.
Citation: Chowdhury T, Kasralikar P, Aleem Syed A, et al. (April 06, 2025) Role of Artificial Intelligence in the Diagnosis of Oral Squamous Cell Carcinoma: A Systematic Review. Cureus 17(4): e81800. DOI 10.7759/cureus.81800
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Winnipeg Free Press
4 hours ago
- Winnipeg Free Press
Bad diets, too many meds, no exercise: A look inside the latest ‘Make America Healthy Again' report
WASHINGTON (AP) — A report that U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has promised will improve the health of America's children does not call on the government to make significant changes to its food or farming policies, according to a draft document obtained by The Associated Press. The 'Make America Healthy Again' strategy report is supposed to be one of Kennedy's signature achievements as the nation's health secretary, giving the government a roadmap to help its citizens lose weight, reduce chronic diseases and exercise more. Before coming to Washington, Kennedy had spent much of his career decrying the harms of chemicals sprayed on crops, prescription drugs, ultraprocessed foods, and vaccines. His coalition, then, has expected him to take bold action as the nation's top health leader. But a draft of the so-called 'MAHA' report, first reported by The New York Times Thursday night, mostly calls on the government to further study chronic diseases, bad air quality, Americans' diets and prescription drug use. The report lays out four problem areas – poor diet, chemical exposure, lack of physical activity and overuse of medications — that are to blame for chronic diseases in the U.S. The White House has held off on publicly releasing the report, which was submitted to President Donald Trump on Tuesday. The latest report is the policy companion to a 'MAHA' report released in May, which was found to have several errors in it. White House spokesman Kush Desai refused to confirm whether the copy obtained by the Associated Press was a final version, though HHS officials have insisted the report has been finalized since Tuesday. 'President Trump pledged to Make America Healthy Again, and the Administration is committed to delivering on that pledge with Gold Standard Science,' Desai said. 'Until officially released by the White House and MAHA Commission, however, any documents purporting to be the second MAHA Report should be considered as nothing more than speculative literature.' Some in the agricultural industry had warily anticipated the report, fearing it would call for bans or investigations into the use of pesticides and herbicides that farmers in the U.S. regularly spray on crops to control weeds and enhance yields. Other farmers were concerned about how the report may target the use of corn syrup, a common sweetener, in American foods. Both products have been a central talking point in Kennedy's 'MAHA' movement, which has attracted a diverse coalition of suburban and rural moms, Trump supporters and liberals concerned about the nation's food supply. Instead, the report calls for an 'awareness' campaign to raise confidence in pesticides. Concerns from the agricultural industry waned as the report hit the president's desk, with one of Kennedy's closest advisers, Calley Means, calling for MAHA supporters to work with major farm companies on Tuesday. Means also acknowledged that the 'pace of political change' can be frustrating. 'We need to build bridges,' Means said, adding that: 'We are not going to win if the soybean farmers and the corn growers are our enemy.' Wednesdays What's next in arts, life and pop culture. Means did not respond to a request for comment on Friday. A spokesman for Kennedy also declined to comment. The report urges the National Institutes of Health – which is facing a 40% cut to its budget under the Trump administration – to undertake several studies on Americans' health, including research on vaccine injury, autism, air quality, water quality, prescription drugs, and nutrition. The report also calls for changes to the foods served in schools and hospitals, something that will be hard to deliver with the Trump administration's funding cuts, said Kari Hamerschlag, the deputy director of the food and agriculture at the nonprofit Friends of the Earth. Earlier this year, the Republican-led administration wiped out $1 billion set aside that helped food banks and schools procure food directly from local farmers. 'This is not going to transform our food and farming system,' Hamerschlag said. 'This is not going to make people healthier. They need to put resources behind their recommendations.' ___
CTV News
6 hours ago
- CTV News
Lilly signs US$1.3 billion deal with Superluminal to discover obesity medicines using AI
A sign for Eli Lilly & Co. stands outside their corporate headquarters in Indianapolis. (AP Photo/Darron Cummings, File) Eli Lilly has signed a deal worth US$1.3 billion with privately held Superluminal Medicines to discover and develop small-molecule drugs through AI to treat obesity and other cardiometabolic diseases. Lilly currently dominates the obesity treatment market, estimated to be worth $150 billion by the next decade, and is trying to strengthen its foothold in the space through the development of next-generation drugs, acquisitions and partnerships. The deal gives Lilly exclusive rights to develop and commercialize drug candidates discovered using Superluminal's proprietary AI-driven platform targeting G-protein-coupled receptors (GPCR) - a class of proteins that can influence physiological processes including metabolism, cell growth and immune responses - the drug developer said on Thursday. Drugmakers including Danish rival Novo Nordisk are exploring potential GPCR targets to develop oral small-molecule drugs for obesity. 'GPCRs have established themselves as very important targets in the obesity and cardiometabolic landscape, but we're at the very early stages of exploration of the target class,' Superluminal CEO Cony D'Cruz told Reuters. Novo struck a $2.2 billion deal with U.S. biotech Septerna in May to develop small-molecule therapies directed at select GPCR targets. Lilly has been capitalizing on the overwhelming popularity of the GLP-1 class of medicines, including its blockbuster drug Zepbound as well as Novo's Wegovy. It is also developing a keenly watched oral GLP-1 drug, orforglipron, which has failed to meet investor expectations. The drugmaker teamed up with Hong Kong-listed biotech Laekna last year to develop an experimental obesity drug that aims to help patients lose weight while preserving muscle. As part of the deal, Superluminal is eligible to receive upfront and milestone payments, an equity investment as well as tiered royalties on net sales, the company said. Boston-based startup Superluminal is developing a wholly owned lead candidate targeting a protein called melanocortin 4 receptor to treat certain rare, genetic forms of obesity and is expected to begin human trials by fourth quarter next year. The lead candidate is not part of the deal with Lilly. Superluminal is backed by investors including RA Capital Management, Insight Partners and NVentures, NVIDIA's venture capital arm. (Reporting by Mariam Sunny in Bengaluru; Editing by Pooja Desai)
Winnipeg Free Press
a day ago
- Winnipeg Free Press
A look at CP's coverage plans for back to school 2025
Parents and students prepping for another year of classes do so amid challenges new and old: emerging tech, rising costs, infection fears, divisive politics and bullying. Not to mention the seemingly constant dilemma of what to put in your kids' lunchbox. Here's a look at the features and explainers planned by The Canadian Press as families gear up for a new school year. Stories and approximate run dates: Harvard-Canadians: The Trump administration's decision to bar international students from Harvard earlier this year left Canadian students who had hopes for completing their Ivy League education at the Massachusetts school anxious about their futures. We check back in with them as the school year approaches. By Cassidy McMackon. Moves Aug 15. Measles-Vaccine-Schedule: Some provinces give the second dose of the measles vaccine at 18 months, while others don't give the second dose until age four. This means that some kids in Ontario, for instance, might be entering school without being fully protected amid the province's outbreak that has sickened more than 2,000 people. Here's what the experts say parents should know about the different schedule, and why they should consider fully vaccinating their toddlers before September. By Hannah Alberga. Aug. 18. Cda-Universities-AI: A look at how Canadian universities are navigating the use of artificial intelligence by students and teachers — and how schools are trying to ensure the technology improves learning outcomes rather than worsening them. Maan Alhmidi. Aug. 19 Teaching-Influencing: Gen Z increasingly sees influencer marketing as a viable career choice and several Canadian school are pitching courses teaching them to become just that— what skills to they teach, and how popular are they? By Nicole Thompson. Moves Aug. 21. Teaching-Climate-Change: Teachers share how they use major weather events to help explain the impact of climate change to children, but face restrictions with the current curriculum. By Cassidy McMackon. Moves: Aug. 22 Student-Woes-Vignettes: The challenges facing post-secondary students have been amplified by a cost-of-living crisis, fractured political climate and increasing social isolation driven in part by AI and smartphone technology. We speak to some of them about their lives. By Rianna Lim. Aug. 24 Young-Influencers: A look at how some young influencers plan to navigate their studies with their plans to continue posting about their lives online — especially those whose profiles blew up over the summer. By Vanessa Tibeiro. Moves Aug. 25. Financial-Literacy: Recent data shows Gen Z is better at saving than Millennials, with many saying they learn about finances online. A look at how even those who are minors are taught about money, and what's behind the increased awareness as young people prepare to enter into a cost-of-living crisis. By Natasha Baldin. Aug. 26 School-Lunches: Many parents who aren't Meghan Markle dread planning school lunches. How to master package-less, nut-free, whole-food meals to satiate picky eaters in a rush. By Cassandra Szklarski. Aug. 27 Medical-School-Students: We talk to first-year medical students who are the first in their family to pursue a career as a doctor and have faced racial, economic or social barriers to get there. By Nicole Ireland. Aug. 30 Bullying-Prep: Tips on how Black, racialized and neurodiverse youth can navigate social and school situations safely. By Cassandra Szklarski/Nicole Thompson. Sept. 2
